Survival and treatment outcomes in patients with leptomeningeal disease from metastatic melanoma.

Chantal SaberianDenái R MiltonJulie SimonRodabe N AmariaAdi DiabJennifer McQuadeSapna P PatelHussein A TawbiCassian YeeMichael K WongIan E McCutcheonMichael A DaviesSherise D FergusonIsabella C Glitza Oliva

Published in: Neuro-oncology practice (2024)

Despite many advances in therapeutic options, the outcomes of melanoma patients with LMD remains poor. However, a subset of patients appears to derive benefit from LMD-directed treatment.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
prognostic factors
peritoneal dialysis
type diabetes
metabolic syndrome
adipose tissue
skeletal muscle
combination therapy
patient reported
glycemic control
skin cancer